Patients with nonspecific ulcerative colitis and Crohn’s disease are being treated by Mesenchymal Stem Cells (ucbMSCs). This transplantation helps patients with both acute and chronic types of nonspecific inflammatory bowel conditions.

Some indication that the patient needs ucbMSCs are –

• When the disease advances irrespective of conservative therapy for 2 weeks
• Presence of extraenteric complications
• No possibility of surgery because conditions of anemia, metabolic disorders or hypoproteinemia
• Exhaustion
• When Transfusion is not possible because of difficulty in finding the same blood group

After stem cell treatment, there is a restoration of RBC and hemoglobin levels are normalized. ucbMSCs also stops the advancement of an auto-immune process, and restores immunocompetency in patients. Remission in these patients with nonspecific ulcerative colitis lasts on an average between 12–15 months, and in patients with Crohn’s disease – for up to 2.5 – 3 years.